Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://ncbi.nlm.nih.gov/pubmed/25985893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1404-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak